Beyond Achondroplasia

Growing together with Clara

July 13, 2018
by inesp.alves
2 Comments

A new step forward for TherAchon: the Dreambird study on Achondroplasia

TherAchon is a Biotechnology company that was established in 2014 and focuses on rare diseases. It is developing a drug for achondroplasia in particular: TA-46, which is planned to go onto phase I clinical trials in 2019 [1]. In order to … Continue reading

Translate »